143 related articles for article (PubMed ID: 23571646)
21. Multiple autoimmune syndrome in a patient with pemphigus vulgaris.
Grandhe NP; Dogra S; Kanwar AJ
Acta Derm Venereol; 2005; 85(1):91-2. PubMed ID: 15849009
[No Abstract] [Full Text] [Related]
22. Dyskeratosis of the Face: A Quiz.
Vuong V; Vuong V; Monsel G; Cavelier-Balloy B; Battistella M; Collet E; Bagot M; Basset-Seguin N; Viguier M
Acta Derm Venereol; 2016 Feb; 96(2):285-7. PubMed ID: 26258665
[No Abstract] [Full Text] [Related]
23. [Association of seborrheic pemphigus and Hashimoto autoimmune thyroiditis. Apropos of a further case].
Goucha S; Mokhtar I; Fazaa B; Yaalaoui S; Zéglaoui F; Kamoun MR
Rev Med Interne; 2002 Mar; 23(3):336-7. PubMed ID: 11928385
[No Abstract] [Full Text] [Related]
24. Assessment of the therapeutic benefit of oral prednisolone and common adjuvant therapy in stage II of randomized controlled trial study for management of pemphigus vulgaris.
Esmaili N; Chams-Davatchi C; Valikhani M; Daneshpazhooh M; Toosi S; Karimi A; Mortazavi H
Arch Iran Med; 2014 Sep; 17(9):626-8. PubMed ID: 25204479
[TBL] [Abstract][Full Text] [Related]
25. Immunoablative high-dose cyclophosphamide without stem cell rescue in pemphigus foliaceus.
Cohen MA; Cohen JJ; Kerdel FA
Int J Dermatol; 2002 Jun; 41(6):340-4. PubMed ID: 12100688
[TBL] [Abstract][Full Text] [Related]
26. The adjuvant therapy of pemphigus. An update.
Bystryn JC; Steinman NM
Arch Dermatol; 1996 Feb; 132(2):203-12. PubMed ID: 8629830
[TBL] [Abstract][Full Text] [Related]
27. Dexamethasone pulse therapy: evidence for no benefit in pemphigus.
Jonkman MF
Indian J Dermatol Venereol Leprol; 2011; 77(2):190-1; author reply 191-2. PubMed ID: 21393952
[No Abstract] [Full Text] [Related]
28. Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial.
Mentink LF; Mackenzie MW; Tóth GG; Laseur M; Lambert FP; Veeger NJ; Cianchini G; Pavlovic MD; Jonkman MF
Arch Dermatol; 2006 May; 142(5):570-6. PubMed ID: 16702494
[TBL] [Abstract][Full Text] [Related]
29. Dexamethasone-cyclophosphamide pulse therapy for pemphigus.
Pasricha JS; Khaitan BK; Raman RS; Chandra M
Int J Dermatol; 1995 Dec; 34(12):875-82. PubMed ID: 8647673
[TBL] [Abstract][Full Text] [Related]
30. Current regimen of pulse therapy for pemphigus: minor modifications, improved results.
Pasricha JS;
Indian J Dermatol Venereol Leprol; 2008; 74(3):217-21. PubMed ID: 18583786
[TBL] [Abstract][Full Text] [Related]
31. Dexamethasone-cyclophosphamide pulse therapy in pemphigus.
Manzoor S; Bhat Y; Ahmad S; ;
Indian J Dermatol Venereol Leprol; 2009; 75(2):184-6. PubMed ID: 19293511
[No Abstract] [Full Text] [Related]
32. Mycophenolate mofetil as adjuvant in pemphigus vulgaris.
Sarma N; Ghosh S
Indian J Dermatol Venereol Leprol; 2007; 73(5):348-50. PubMed ID: 17921620
[TBL] [Abstract][Full Text] [Related]
33. Immunoablative high-dose cyclophosphamide without stem cell rescue in a patient with pemphigus vulgaris.
Hayag MV; Cohen JA; Kerdel FA
J Am Acad Dermatol; 2000 Dec; 43(6):1065-9. PubMed ID: 11100024
[TBL] [Abstract][Full Text] [Related]
34. [Localized pemphigus].
Kharfi M; Fazaa B; Benmously R; Bouden S; Elloumi L; Kamoun MR
Ann Dermatol Venereol; 2003; 130(6-7):645-7. PubMed ID: 13679705
[No Abstract] [Full Text] [Related]
35. Mild pemphigus foliaceus responding to combination therapy with niacinamide and tetracycline.
Chen S; Lu X; Zhou G
Int J Dermatol; 2003 Dec; 42(12):981-2. PubMed ID: 14636199
[No Abstract] [Full Text] [Related]
36. A rare cause of unilateral facial rash.
Krase IZ; Wickenheiser M; Chao J; Kurtzman D; Segal R; Culpepper K; Shi V
Clin Exp Dermatol; 2019 Jun; 44(4):425-427. PubMed ID: 30229995
[No Abstract] [Full Text] [Related]
37. Curative effect of dexamethasone-cyclophosphamide pulse therapy for the treatment of pemphigus vulgaris.
Pasricha JS; Das SS
Int J Dermatol; 1992 Dec; 31(12):875-7. PubMed ID: 1478770
[TBL] [Abstract][Full Text] [Related]
38. Unusual Histological Evidence of Dysplasia in a Case of Oral Pemphigus Vulgaris: A Potential Diagnostic Challenge.
Gissi DB; Tarsitano A; Baldovini C; Gabusi A
Int J Surg Pathol; 2016 Dec; 24(8):733-737. PubMed ID: 27305938
[TBL] [Abstract][Full Text] [Related]
39. Oral pemphigus: long term behaviour and clinical response to treatment with deflazacort in sixteen cases.
Mignogna MD; Lo Muzio L; Mignogna RE; Carbone R; Ruoppo E; Bucci E
J Oral Pathol Med; 2000 Apr; 29(4):145-52. PubMed ID: 10766391
[TBL] [Abstract][Full Text] [Related]
40. Assessment of the therapeutic benefit of dexamethasone cyclophosphamide pulse versus only oral cyclophosphamide in phase II of the dexamethasone cyclophosphamide pulse therapy: a preliminary prospective randomized controlled study.
Parmar NV; Kanwar AJ; Minz RW; Parsad D; Vinay K; Tsuruta D; Ishii N; Hashimoto T
Indian J Dermatol Venereol Leprol; 2013; 79(1):70-6. PubMed ID: 23254732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
